Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1a, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

Next Previous
Trial Profile

A Phase 1a, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 01 Mar 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs VIR 1111 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; First in man; Pharmacodynamics; Proof of concept
  • Sponsors Vir Biotechnology

Most Recent Events

  • 24 Feb 2023 Status changed from active, no longer recruiting to completed.
  • 03 Nov 2022 According to a Vir Biotechnology media release, safety and immunology data from the highest dose cohort 3 are expected in the first half of 2023.
  • 09 Aug 2022 According to a Vir Biotechnology media release, data from this trial is expected in second half of 2022.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top